Volltext-Downloads (blau) und Frontdoor-Views (grau)

The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective

  • Quantitative estimates for the global impact of COVID-19 on the diagnosis and management of patients with inborn errors of metabolism (IEM) are lacking. We collected relevant data from 16 specialized medical centers treating IEM patients in Europe, Asia and Africa. The median decline of reported IEM related services in March 1st-May 31st 2020 compared to the same period in 2019 were as high as 60-80% with a profound impact on patient management and care for this vulnerable patient group. More representative data along with outcome data and guidelines for managing IEM disorders under such extraordinary circumstances are needed.

Export metadata

Additional Services

Share in Twitter Search Google Scholar Availability


Document Type:Article
Author:Mohamed A. Elmonem, Amaya Belanger-Quintana, Andrea Bordugo, Ritma Boruah, Elisenda Cortès-Saladelafont, Mounika Endrakanti, Pilar Giraldo, Sarah Catharina Grünert, Neerja Gupta, Madhulika Kabra, Ina Knerr, Johannes Krämer, Alice Kuster, Elena Levtchenko, Lock-Hock Ngu, M. Mar Rovira-Remisa, Jörn Oliver Sass, Jolanta Sykut-Cegielska, Albina Tummolo, Lambertus P. van den Heuvel
Parent Title (English):Molecular Genetics and Metabolism
Pubmed Id:http://www.ncbi.nlm.nih.gov/pubmed?term=33004274
Date of first publication:2020/09/25
Submission status:In Press, Corrected Proof
© 2020 Elsevier Inc. All rights reserved.
Tag:Health care policy; Inherited metabolic disorders; SARS-COV-2 virus; Survey; Telemedicine
Dewey Decimal Classification (DDC):5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 576 Genetik und Evolution
Entry in this database:2020/10/06